NUTX Nutex Health Inc.
Services-Business Services, NEC · Nasdaq · SEC CIK 1479681 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-18.8%
TTM net income YoY36.5%
TTM EPS YoY20.0%
Revenue 3-yr CAGR50.9%
Net income 3-yr CAGR—
Margins
Gross margin47.8%
Operating margin39.0%
Net margin20.7%
FCF margin31.1%
EBITDA margin41.8%
Returns
ROE43.8%
ROA16.5%
ROIC (approx.)117.4%
Asset turnover0.80x
Leverage & solvency
Liabilities / assets47.6%
Debt / equity0.10x
Current ratio4.76x
Interest coverage16.21x
Cash quality & payout
Operating cash flow / net income1.57x
Accruals ratio-9.4%
Payout ratio—
Capex / revenue1.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q42024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $217.61M | $210.75M | $216.49M | $151.68M | $267.80M | $243.99M | $211.79M | $257.62M |
| Gross profit | $101.53M | $141.28M | $91.73M | $46.14M | $154.88M | $124.92M | $118.34M | $141.63M |
| SG&A expense | $17.04M | $16.68M | $14.38M | $17.82M | $11.30M | $12.50M | $10.04M | $12.75M |
| Operating income | $77.10M | $121.72M | $81.27M | $30.92M | $130.37M | $33.68M | $80.66M | $114.21M |
| Interest expense | $4.86M | $4.67M | $4.68M | $4.98M | $5.45M | $5.68M | $6.12M | $5.05M |
| Pretax income | $72.54M | $117.08M | $76.56M | $25.89M | $123.94M | $23.73M | $71.22M | $108.58M |
| Income tax | $15.20M | $20.77M | $13.80M | $9.29M | $27.14M | $7.59M | $20.41M | $8.61M |
| Net income | $40.23M | $65.84M | $46.81M | $11.83M | $55.44M | -$17.70M | $21.22M | $61.70M |
| EBITDA | $82.72M | $127.03M | $86.76M | $36.10M | $135.37M | $38.93M | $85.75M | $119.49M |
| EPS (basic) | 5.87 | 9.58 | 6.70 | — | 8.27 | -2.95 | 3.74 | 11.83 |
| EPS (diluted) | 5.71 | 9.38 | 6.52 | — | 7.76 | -2.95 | 3.33 | 11.12 |
| Weighted avg. shares (diluted) | 7.04M | 7.02M | 7.18M | — | 7.18M | 5.99M | 6.45M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $249.91M | $205.21M | $207.35M | $185.57M | $166.05M | $96.73M | $84.73M | $40.64M |
| Receivables | — | — | — | — | — | — | $295.08M | $232.45M |
| Inventory | $5.14M | $4.21M | $4.68M | $2.87M | $3.16M | $2.27M | $3.12M | $2.85M |
| Current assets | $633.24M | $585.65M | $579.65M | $538.81M | $592.65M | $473.02M | $401.52M | $292.48M |
| PP&E, net | $103.24M | $95.70M | $94.93M | $94.58M | $82.82M | $82.92M | $76.43M | $77.93M |
| Goodwill | $13.92M | $13.92M | $13.92M | $13.92M | $13.92M | $13.92M | $13.92M | $13.92M |
| Intangibles | $20.25M | $20.58M | $20.91M | $21.23M | $21.55M | $14.88M | $15.21M | $15.53M |
| Total assets | $1.03B | $964.63M | $957.32M | $918.52M | $964.52M | $841.03M | $761.92M | $655.32M |
| Current liabilities | $132.94M | $117.22M | $184.44M | $157.91M | $185.46M | $194.87M | $196.18M | $154.22M |
| Short-term debt | $8.10M | $8.50M | $16.73M | $13.34M | $18.00M | $18.95M | $13.63M | $14.39M |
| Long-term debt | $34.20M | $31.11M | $24.26M | $29.17M | $25.57M | $20.46M | $21.73M | $22.47M |
| Total debt | $42.30M | $39.60M | $40.99M | $42.51M | $43.58M | $39.41M | $35.37M | $36.86M |
| Total liabilities | $491.47M | $457.32M | $515.26M | $495.09M | $526.49M | $504.15M | $506.65M | $466.79M |
| Shareholders' equity | $435.57M | $394.32M | $346.29M | $329.45M | $317.17M | $235.25M | $176.95M | $132.44M |
| Net debt | -$207.61M | -$165.61M | -$166.36M | -$143.06M | -$122.47M | -$57.32M | -$49.36M | -$3.78M |
| Shares outstanding | 6.86M | 6.84M | 6.95M | 7.09M | 6.91M | 6.60M | 5.95M | 5.51M |
| Cash flow statement | ||||||||
| Operating cash flow | $78.35M | $34.20M | $75.52M | $70.39M | $99.51M | $27.26M | $50.97M | $54,000 |
| Capital expenditure | $5.20M | $2.54M | $1.20M | $1.41M | $302,000 | $751,000 | $64,000 | $394,897 |
| Free cash flow | $73.14M | $31.66M | $74.32M | $68.98M | $99.21M | $26.51M | $50.90M | -$340,897 |
| Investing cash flow | -$5.20M | -$2.54M | -$1.20M | -$5.07M | -$302,000 | $196,000 | -$64,000 | -$3.34M |
| Financing cash flow | -$26.69M | -$35.19M | -$49.55M | -$45.79M | -$29.90M | -$15.45M | -$6.81M | -$2.99M |
| Depreciation & amortization | $5.62M | $5.32M | $5.49M | $5.19M | $5.00M | $5.25M | $5.09M | $5.28M |
| Stock-based compensation | — | — | — | $0 | $22.88M | $68.96M | $15.94M | — |
| Share buybacks | $1,000 | $18.96M | $31.73M | $5.00M | $0 | $0 | $0 | — |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.